22.36
전일 마감가:
$22.10
열려 있는:
$22.09
하루 거래량:
5,590
Relative Volume:
0.05
시가총액:
$464.26M
수익:
-
순이익/손실:
-
주가수익비율:
-0.7465
EPS:
-29.96
순현금흐름:
-
1주 성능:
+8.78%
1개월 성능:
+8.41%
6개월 성능:
+69.93%
1년 성능:
+84.84%
Shoulder Innovations Inc Stock (SI) Company Profile
명칭
Shoulder Innovations Inc
전화
616-566-0286
주소
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS
Compare SI vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SI
Shoulder Innovations Inc
|
22.30 | 484.25M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
114.48 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.81 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.26 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.71 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.75 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | BTIG Research | Buy |
| 2025-08-25 | 개시 | Goldman | Buy |
| 2025-08-25 | 개시 | Jefferies | Buy |
| 2025-08-25 | 개시 | Piper Sandler | Overweight |
| 2023-03-06 | 다운그레이드 | Compass Point | Neutral → Sell |
| 2023-03-06 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2023-03-02 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | 다운그레이드 | Compass Point | Buy → Neutral |
| 2023-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-03-01 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-01-06 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-01-06 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2023-01-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-12 | 재확인 | Wedbush | Outperform |
| 2022-12-05 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-10-26 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-06 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | 개시 | BTIG Research | Buy |
| 2022-06-13 | 개시 | Wells Fargo | Overweight |
| 2022-06-09 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-03-21 | 개시 | BofA Securities | Buy |
| 2022-01-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-12-16 | 개시 | B. Riley Securities | Buy |
| 2021-11-11 | 개시 | JP Morgan | Overweight |
| 2021-11-08 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | 개시 | Morgan Stanley | Overweight |
| 2021-06-14 | 개시 | Goldman | Neutral |
| 2021-01-14 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-12-22 | 개시 | Wedbush | Outperform |
| 2020-12-17 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | 개시 | Craig Hallum | Buy |
| 2020-10-16 | 개시 | Compass Point | Buy |
| 2020-03-16 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | 개시 | Barclays | Overweight |
| 2019-11-18 | 개시 | Compass Point | Buy |
모두보기
Shoulder Innovations Inc 주식(SI)의 최신 뉴스
Shoulder Innovations (NYSE:SI) COO Matthew Fraser Ahearn Sells 8,314 Shares of Stock - MarketBeat
Shoulder Innovations (SI) COO sells shares under 10b5-1 plan - Stock Titan
Shoulder Innovations (NYSE: SI) plans 22,500-share sale - Stock Titan
Gilde Healthcare sells $213,479 of Shoulder Innovations stock - Investing.com
Gilde Healthcare sells $213,479 of Shoulder Innovations stock By Investing.com - Investing.com UK
SHOULDER INNOVATIONS, INC. SEC Filing (Aug 14, 2026) - Stock Titan
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer - AOL.com
Shoulder Innovations Inc (SI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Shoulder Innovations at Canaccord Genuity conference: growth, margins rise By Investing.com - Investing.com Canada
Shoulder Innovations at Canaccord Genuity conference: growth, margins rise - Investing.com
Shoulder Innovations announces $4.9M expansion to Byron Center, creating 42 new jobs - FOX 17 West Michigan News
SHOULDER INNOVATIONS, INC. : UBS RAISES TARGET PRICE TO $28 FROM $27 - webull.com
Medical technology company plans new headquarters in Byron Township - Yahoo
Shoulder Innovations elevates Jon Osborne to CCO - medicalbuyer.co.in
Shoulder Innovations, Inc. (NYSE:SI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Shoulder Innovations (SI) CCO Jonathan Osborne reports stock and option stakes - Stock Titan
Shoulder Innovations, Inc. Announces Appointment of Jon Osborne to Chief Commercial Officer, Effective August 6, 2026 - marketscreener.com
Grand Rapids medtech firm raises 2026 forecast as sales surge 56% - Crain's Grand Rapids Business
Jon Osborne Appointed Chief Commercial Officer at Shoulder Innovations - Kalkine Media
UBS Adjusts Shoulder Innovations Price Target to $28 From $27, Maintains Buy Rating - marketscreener.com
Shoulder Innovations promotes Jon Osborne to commercial chief By Investing.com - Investing.com Australia
Shoulder Innovations promotes Jon Osborne to commercial chief - Investing.com
Shoulder Innovations Promotes Jon Osborne to Commercial Chief - TipRanks
Shoulder Innovations Q2 Earnings Call Highlights - sharewise.com
Major Investor Makes Bold Move in Shoulder Innovations, Inc. Shake-Up - TipRanks
Shoulder Innovations (NYSE:SI) Major Shareholder Sells $166,132.32 in Stock - MarketBeat
Shoulder Innovations (NYSE:SI) Major Shareholder Sells $47,347.00 in Stock - MarketBeat
Shoulder Innovations (SI): Gilde Healthcare sells shares, holds 10.7% stake - Stock Titan
Shoulder Innovations (SI) 10% holder sells 9,433 shares - Stock Titan
Piper Sandler Reiterates "Overweight" Rating for Shoulder Innovations (NYSE:SI) - MarketBeat
BTIG Research Increases Shoulder Innovations (NYSE:SI) Price Target to $26.00 - MarketBeat
BTIG Maintains Shoulder Innovations(SI.US) With Buy Rating, Maintains Target Price $26 - Moomoo
Shoulder Innovations,Raises FY2026 Net Rev - Moomoo
Shoulder Innovations Inc (SI) (Q2 2026) Earnings Call Highlights: Revenue Surges 56% as ... - Yahoo Finance UK
Earnings call transcript: Shoulder Innovations posts 56% revenue growth in Q2 2026 - Investing.com Canada
Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance Singapore
Shoulder Innovations Q2 2026 Earnings Call Transcript - MarketBeat
Shoulder Innovations, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Shoulder Innovations (SI) Releases Q2 2026 Earnings: Revenue Growth but EPS Miss - Quiver Quantitative
SHOULDER INNOVATIONS, INC. Q2 2026: Revenue $17.18M, EPS $(0.49) — 10-Q Summary - TradingView
Shoulder Innovations (NYSE: SI) grows H1 2026 revenue 60% while ramping investment - Stock Titan
Shoulder Innovations posts Q2 revenue up 56% to $17.2M, raises 2026 guidance - TradingView
Shoulder Innovations Q2 2026 earnings: 56% revenue growth lifts the outlook - TradingKey
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook - Morningstar
FMR LLC reports 17.7% beneficial ownership in Shoulder Innovations Inc (SI) - Stock Titan
Jonathan E. Osborne Net Worth (2026) - GuruFocus
Major Investor Makes Bold Exit Move in Shoulder Innovations, Inc. - TipRanks
Shoulder Innovations (NYSE:SI) Major Shareholder Sells $2,272,719.24 in Stock - MarketBeat
Shoulder Innovations, Inc. (SI) holder sells 110,563 shares in insider trades - Stock Titan
Shoulder Innovations, Inc. expected to post a loss of 46 cents a shareEarnings Preview - TradingView
Major Investor Makes Bold Move in Shoulder Innovations Stock - TipRanks
Shoulder Innovations Inc (SI) 재무 분석
Shoulder Innovations Inc (SI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):